Aviv Pharma
Reno, US · Founded 2022 · Nevada corporation
Find your way into Aviv Pharma
Sign up to see every warm intro you have to Aviv Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Aviv Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JA
Jeffrey Alan GlazerNamed on SEC filing
RR
Robert Rene RabalaisNamed on SEC filing
RA
Ricardo Alberto HungriaNamed on SEC filing
PA
Philip Arthur EpsteinNamed on SEC filing
JD
Jeffrey David RosenbergNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2.3M disclosed across 1 round · 2023
▶$2.3MraisedDec 2023 · 12 investors · PharmaceuticalsRule 506(c)
▶$2.3MraisedDec 2023 · 12 investors · Pharmaceuticals
Rule 506(c)Officers, directors & promoters on the filing
- Jeffrey Alan GlazerExecutive Officer, Director
- Robert Rene RabalaisDirector
- Ricardo Alberto HungriaDirector
- Philip Arthur EpsteinExecutive Officer, Director
- Jeffrey David RosenbergDirector
- Offering amount
- $4M
- Amount sold
- $2.3M
- Minimum investment
- $25K
- First sale
- Dec 2023
- Incorporated
- Corporation, Nevada, 2022
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Aviv Pharma raised?
- Aviv Pharma has disclosed $2.3M raised across 1 round.
- Where is Aviv Pharma headquartered?
- Aviv Pharma is headquartered in Reno, US.